AD
MC-Val-Cit-PAB-MMAF(CAS: 863971-17-9)
CAS Number
Related Products
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-N-[4-(hydroxymethyl)phenyl]-N~6~-trityl-L-lysinamide](https://static.chemtradehub.com/structs/111/1116085-98-3-1927.webp)
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycine](https://static.chemtradehub.com/structs/356/35665-38-4-ec65.webp)
Monomethyl auristatin E
CAS Number: 474645-27-7
Boc-Dap-NE
CAS Number: 160800-65-7
Boc-Val-Cit-PAB-PNP
CAS Number: 870487-10-8
![N,N-Dimethyl-L-valyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]-1-pyrrolidinyl}-5-methyl-1-oxo-4-heptanyl]-N-methyl-D
-valinamide](https://static.chemtradehub.com/structs/110/110417-88-4-4352.webp)
Fmoc-Val-Cit-PAB-MMAE
CAS Number: 1350456-56-2
![N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-3-methoxy
-5-methyl-1-oxo-4-heptanyl]-N-methyl-L-valinamide](https://static.chemtradehub.com/structs/863/863971-19-1-dde1.webp)
![2-Methyl-2-propanyl [(3S,6S)-6-methyl-3-piperidinyl]carbamate](https://static.chemtradehub.com/structs/193/1932293-70-3-8e9e.webp)
Other Suppliers for MC-Val-Cit-PAB-MMAF
Basic Information
Molecular Formula
C68H103N11O16
Molecular Weight
1330.61 g/mol
Chemical Identifiers
SMILES
CC[C@@H]([C@H](N(C(=O)[C@H](C(C)C)NC(=O)[C@@H](N(C(=O)OCc1ccc(cc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)CCCCCN1C(=O)C=CC1=O)CCCNC(=O)N)C)C(C)C)C)[C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C)OC)OC)C
InChIKey
BDITVJHHJUTHBB-DNIGJBFUSA-N
Database References
MDL Number
MFCD28398145
FAQ
MC-Val-Cit-PAB-MMAF is a cytotoxic compound used in immunoconjugates for targeted cancer therapy. It has a complex structure with a payload of maytansinoid MMAF linked to a carrier peptide. It is not for general use and is primarily used in research and clinical applications.
MC-Val-Cit-PAB-MMAF is primarily used in the development and production of immunoconjugates for targeted cancer therapy. It is used in research and clinical trials to deliver cytotoxic payloads to cancer cells while minimizing damage to healthy cells.
MC-Val-Cit-PAB-MMAF is not considered safe for general use due to its cytotoxic nature. Proper handling and use under laboratory conditions with appropriate protective measures are essential to ensure safety.
MC-Val-Cit-PAB-MMAF should be stored in a cool, dry place away from direct sunlight and heat sources. It should be kept in an airtight container to prevent degradation. Optimal storage conditions are 2-8°C (35-46°F).
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Mr. Liu
jhyylcj@163.c0m